These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 33423969

  • 1. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P, Wang Z, Liu Y, Xie J, Ren Y.
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [Abstract] [Full Text] [Related]

  • 2. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
    Huang MY, Lee HH, Tsai HL, Huang CW, Yeh YS, Ma CJ, Huang CM, Chen CY, Huang JJ, Wang JY.
    Radiat Oncol; 2018 Mar 27; 13(1):53. PubMed ID: 29587797
    [Abstract] [Full Text] [Related]

  • 3. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S, Marginean H, Tang PA, Monzon JG, Raissouni S, Asmis TR, Goodwin RA, Gotfrit J, Cheung WY, Vickers MM.
    BMC Cancer; 2019 Jul 05; 19(1):664. PubMed ID: 31277604
    [Abstract] [Full Text] [Related]

  • 4. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C, Forlin M, Delrio P, Rega D, Degiuli M, Sofia S, Olivieri M, Pucciarelli S, Zuin M, De Manzoni G, Di Leo A, Scabini S, Zorcolo L, Restivo A.
    BMC Cancer; 2018 Nov 12; 18(1):1094. PubMed ID: 30419864
    [Abstract] [Full Text] [Related]

  • 5. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH, Hwang S, Lee SJ, Kang BW, Baek D, Kim HJ, Park SY, Park JS, Choi GS, Kim JC, Cho SH, Kim JG.
    Anticancer Res; 2017 Mar 12; 37(3):1459-1465. PubMed ID: 28314318
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L, Cai S, Xiao T, Chen Y, Qiu H, Wu B, Lin G, Sun X, Lu J, Zhou W, Xiao Y.
    Colorectal Dis; 2017 Jul 12; 19(7):O263-O271. PubMed ID: 28603932
    [Abstract] [Full Text] [Related]

  • 7. High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy.
    Ke TM, Lin LC, Huang CC, Chien YW, Ting WC, Yang CC.
    Medicine (Baltimore); 2020 Apr 12; 99(17):e19877. PubMed ID: 32332656
    [Abstract] [Full Text] [Related]

  • 8. Predictive Value of Leukocyte- and Platelet-Derived Ratios in Rectal Adenocarcinoma.
    Ward WH, Goel N, Ruth KJ, Esposito AC, Lambreton F, Sigurdson ER, Meyer JE, Farma JM.
    J Surg Res; 2018 Dec 12; 232():275-282. PubMed ID: 30463730
    [Abstract] [Full Text] [Related]

  • 9. Prognostic analysis of rectal cancer patients after neoadjuvant chemoradiotherapy: different prognostic factors in patients with different TRGs.
    Tang YL, Li DD, Duan JY, Wang X.
    Int J Colorectal Dis; 2024 Jun 19; 39(1):93. PubMed ID: 38896374
    [Abstract] [Full Text] [Related]

  • 10. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V, López-Campos F, Martin-Martin M, Valero M, Zafra-Martín J, Couñago F, Sancho S.
    Oncology; 2023 Jun 19; 101(6):349-357. PubMed ID: 36273439
    [Abstract] [Full Text] [Related]

  • 11. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L, Zhang H, Liang L, Li G, Fan M, Wu Y, Zhu J, Zhang Z.
    Radiat Oncol; 2014 Dec 18; 9():295. PubMed ID: 25518933
    [Abstract] [Full Text] [Related]

  • 12. Clinical and Prognostic Significance of Pathological and Inflammatory Markers in Mucinous Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy and Curative Surgery.
    Zhao J, Xu J, Zhang R.
    Med Sci Monit; 2017 Oct 08; 23():4826-4833. PubMed ID: 28988257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang Y, Liu X, Xu M, Chen K, Li S, Guan G.
    Sci Rep; 2020 May 15; 10(1):8017. PubMed ID: 32415197
    [Abstract] [Full Text] [Related]

  • 18. Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection.
    Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V.
    J Gastrointest Surg; 2018 Sep 15; 22(9):1611-1618. PubMed ID: 29687424
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH, Baumann D, Zwirner K, Eipper E, Hauth F, Peter A, Zips D, Gani C.
    Int J Mol Sci; 2019 May 17; 20(10):. PubMed ID: 31108935
    [Abstract] [Full Text] [Related]

  • 20. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer.
    Xia LJ, Li W, Zhai JC, Yan CW, Chen JB, Yang H.
    BMC Cancer; 2020 Mar 12; 20(1):208. PubMed ID: 32164623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.